{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:45:41Z","timestamp":1775123141199,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 22-month-old boy diagnosed with neuroblastoma was evaluated by bone scintigraphy and <jats:sup>123<\/jats:sup>I-metaiodobenzylguanidine scintigraphy, and no metastases to skeletal system was detected. However, plain radiograph and MRI revealed suspected metastatic lesions. The patient was therefore evaluated by <jats:sup>68<\/jats:sup>Ga-DOTA-TATE PET\/CT, and <jats:sup>68<\/jats:sup>Ga-DOTA-TATE uptake was observed in multiple bone and bone marrow areas, which were consistent with metastases. Biopsy was taken from the right iliac bone, and the pathological examination of the biopsy specimen was coherent with neuroblastoma invasion.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002539","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T21:29:20Z","timestamp":1553549360000},"page":"467-468","source":"Crossref","is-referenced-by-count":14,"title":["68Ga-DOTA-TATE in Neuroblastoma With Marrow Involvement"],"prefix":"10.1097","volume":"44","author":[{"given":"Nese","family":"Torun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/RLU.0000000000001749","article-title":"Metastatic neuroblastoma in adult patient, presenting as a super scan on 68Ga-DOTANOC PET\/CT Imaging","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","article-title":"Guidelines on nuclear medicine imaging in neuroblastoma","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/RLU.0000000000001984","article-title":"SPECT\/CT MIBG Imaging is crucial in the follow-up of the patients with high-risk neuroblastoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib4-20230925","first-page":"1352","article-title":"Specificity of radioiodinated MIBG for neural crest tumors in childhood","volume":"3","year":"1997","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1874471011666171215093112","article-title":"Review: the role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma","volume":"11","year":"2018","journal-title":"Curr Radiopharm"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MPH.0000000000000411","article-title":"Initial experience with gallium-68 DOTA-octreotate PET\/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma","volume":"38","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"Ga-68 DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00259-011-1962-2","article-title":"Functional imaging in phaeochromocytoma and neuroblastoma with Ga-68 DOTA-Tyr3-octreotide positron emission tomography and I-123 metaiodobenzylguanidine: a clarification","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2967\/jnumed.110.085100","article-title":"Lu-177 DOTATATE molecular radiotherapy for childhood neuroblastoma","volume":"52","year":"2011","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:12:20Z","timestamp":1695618740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002539","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}